LifeMD Inc (LFMD)

Currency in USD
4.49
-0.78(-14.80%)
Closed·
4.41-0.08(-1.78%)
·
LFMD is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
4.335.01
52 wk Range
2.5615.84
Key Statistics
Prev. Close
5.27
Open
4.76
Day's Range
4.33-5.01
52 wk Range
2.56-15.84
Volume
2.31M
Average Volume (3m)
1.24M
1-Year Change
-42.1973%
Book Value / Share
0.48
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
LFMD Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
9.88
Upside
+119.93%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year

LifeMD Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

8 Buy
0 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 9.88
(+119.93% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Mizuho
Buy8.00+78.17%6.00Upgrade16/03/2026
Freedom Capital Markets
Buy10.00+122.72%8.00Maintain12/03/2026
H.C. Wainwright
Buy10.00+122.72%9.00Maintain11/03/2026
Cantor Fitzgerald
Buy15.00+234.08%15.00Maintain10/03/2026
H.C. Wainwright
Buy9.00+100.45%-Maintain06/01/2026

LifeMD Inc Earnings Call Summary for Q1/2026

  • LifeMD Q1 2026 EPS of -$0.20 beat forecast of -$0.21; revenue of $50.2M exceeded estimates of $48.88M, driving 2.73% stock gain after-hours.
  • Active subscribers surged 26% YoY to 365,000+; gross margin expanded 420 bps to 88% through improved shipping and fulfillment cost efficiencies.
  • Company reaffirmed FY 2026 revenue guidance of $220-$230M (13-19% growth) with adjusted EBITDA of $12-$17M; profitability expected H2 2026.
  • CEO Schreiber highlighted strategic pharma partnerships with Novo Nordisk and Eli Lilly, plus AI integration as key growth drivers for enhanced economics.
  • GAAP net loss widened to $9.6M from $2.4M prior year amid increased marketing spend; flat YoY revenue growth presents near-term expansion challenges.
Last Updated: 06/05/2026, 22:38
Read Full Transcript

Earnings

Latest Release
06/05/2026
EPS / Forecast
-0.20 / -0.21
Revenue / Forecast
50.2M / 48.88M
EPS Revisions
Last 90 days

LifeMD (LFMD) Income Statement & Profits

Compare LFMD to Peers and Sector

Metrics to compare
LFMD
Peers
Sector
Relationship
P/E Ratio
−10.2x0.0x−0.6x
PEG Ratio
−0.12−0.010.00
Price/Book
14.4x1.0x2.6x
Price / LTM Sales
1.1x1.2x3.2x
Upside (Analyst Target)
89.8%38.1%48.1%
Fair Value Upside
Unlock36.5%5.8%Unlock

LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States. It offers telehealth platform comprising Rex MD, a men’s telehealth platform that provides virtual diagnosis, treatment, and prescription medications for men’s health conditions, including erectile dysfunction, premature ejaculation, hair loss, insomnia, weight loss, and performance anxiety; and ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss. The company also provides LifeMD PC, a virtual primary care and telehealth service which is a provider for their primary care, urgent care, and chronic care needs; and offers virtual medical care, including on-demand consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, integration with in-home tools, and more. In addition, it offers GLP-1 for weight management and in-home health monitoring devices. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
7.57M15.77%33.97M
Other Institutional Investors
13.14M27.38%58.98M
Public Companies & Retail Investors
27.27M56.85%122.46M
Total
47.97M100.00%215.4M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
BlackRock, Inc.5.87%2,814,76912,638
The Vanguard Group, Inc.4.21%2,021,7049,077

People Also Watch

64.070
ORKA
-8.20%
11.280
PRCH
+1.62%
2.75
QTRX
-16.41%
2.1600
ELAB
+1.41%

FAQ

What Is the LifeMD (NASDAQ: LFMD) Share Price Today?

The LifeMD stock price today is 4.49 USD.

What Stock Exchange Does LifeMD (LFMD) Trade On?

LifeMD is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for LifeMD?

The stock symbol (also called a 'ticker') for LifeMD is "LFMD."

What Is the Current LifeMD Market Capitalisation?

As of today, LifeMD (NASDAQ: LFMD) market cap is 254.87M USD.

What Is LifeMD's (LFMD) Earnings Per Share (TTM)?

The LifeMD EPS is currently -0.32 (Trailing Twelve Months).

When Is the Next LifeMD Earnings Date?

LifeMD's next earnings report will be released on 06/08/2026.

Is LFMD a Buy or Sell From a Technical Analyst Perspective?

Based on today's LifeMD moving averages and other technical indicators, the daily buy/sell signal for LFMD stock is Neutral.

How Many Times Has LifeMD Stock Split?

LifeMD has split 1 times. (See the LFMD stock split history page for full effective split date and price information.)

How Many Employees Does LifeMD Have?

LifeMD has 350 employees, based on their latest Companies House report.

What is the current trading status of LifeMD (NASDAQ: LFMD)?

As of 08/05/2026, LifeMD (LFMD) is trading at a share price of 4.49 USD, with a previous close of 5.27 USD. The stock has fluctuated within a day range of 4.33 USD to 5.01 USD, while its 52-week range spans from 2.56 USD to 15.84 USD.

What Is LifeMD (LFMD) Price Target According to Analysts?

The average 12-month price target for LifeMD is 9.88 USD, with a high estimate of 15 USD and a low estimate of 8 USD. 8 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +119.93% Upside potential.

What Is the LFMD Premarket Price?

LFMD's last pre-market stock price is 4.71 USD. The pre-market share volume is 56,870.00, and the stock has decreased by -0.56, or -10.63%.

What Is the LFMD After Hours Price?

LFMD's last after hours stock price is 4.41 USD, the stock has decreased by -0.08, or -1.78%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.